article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

article thumbnail

mRNA: A New Era in Biopharmaceutical Contract Manufacturing Market

Roots Analysis

mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases. However, synthesis and manufacturing of mRNA is fraught with several challenges as the production of such biomolecules is complex, cost intensive, requires specialized expertise and dedicated equipment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality

Roots Analysis

As a result, biopharmaceutical contract manufacturing has picked up pace in the recent years. Overview of Biopharmaceuticals Biopharmaceuticals refer to medicinal / therapeutic products that are either manufactured using living organisms or semi-synthesized from biological sources.

article thumbnail

Biopharmaceutical Contract Manufacturing: Transforming Promise into Reality

Roots Analysis

As a result, biopharmaceutical contract manufacturing has picked up pace in the recent years. Overview of Biopharmaceuticals Biopharmaceuticals refer to medicinal / therapeutic products that are either manufactured using living organisms or semi-synthesized from biological sources.

article thumbnail

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.

article thumbnail

Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com

BioTech 365

Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com Global Pharmaceutical Contract Manufacturing Market 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)

article thumbnail

Charles River inks viral vector production pact for Navega's chronic pain gene therapy

Fierce Pharma

After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an adeno-asso | After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy (..)